These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 12464556)
1. An in-vitro screening assay for the detection of inhibitors of proinflammatory cytokine synthesis: a useful tool for the development of new antiarthritic and disease modifying drugs. Laufer S; Greim C; Bertsche T Osteoarthritis Cartilage; 2002 Dec; 10(12):961-7. PubMed ID: 12464556 [TBL] [Abstract][Full Text] [Related]
2. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. Underwood DC; Osborn RR; Kotzer CJ; Adams JL; Lee JC; Webb EF; Carpenter DC; Bochnowicz S; Thomas HC; Hay DW; Griswold DE J Pharmacol Exp Ther; 2000 Apr; 293(1):281-8. PubMed ID: 10734180 [TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines. Weiss T; Shalit I; Blau H; Werber S; Halperin D; Levitov A; Fabian I Antimicrob Agents Chemother; 2004 Jun; 48(6):1974-82. PubMed ID: 15155187 [TBL] [Abstract][Full Text] [Related]
4. A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation. Mourey RJ; Burnette BL; Brustkern SJ; Daniels JS; Hirsch JL; Hood WF; Meyers MJ; Mnich SJ; Pierce BS; Saabye MJ; Schindler JF; South SA; Webb EG; Zhang J; Anderson DR J Pharmacol Exp Ther; 2010 Jun; 333(3):797-807. PubMed ID: 20237073 [TBL] [Abstract][Full Text] [Related]
5. Imidazole inhibitors of cytokine release: probing substituents in the 2 position. Laufer SA; Striegel HG; Wagner GK J Med Chem; 2002 Oct; 45(21):4695-705. PubMed ID: 12361396 [TBL] [Abstract][Full Text] [Related]
6. ERK1/2 and JNKs, but not p38 kinase, are involved in reactive oxygen species-mediated induction of osteopontin gene expression by angiotensin II and interleukin-1beta in adult rat cardiac fibroblasts. Xie Z; Singh M; Singh K J Cell Physiol; 2004 Mar; 198(3):399-407. PubMed ID: 14755545 [TBL] [Abstract][Full Text] [Related]
7. Monocyte intracellular cytokine production during human endotoxaemia with or without a second in vitro LPS challenge: effect of RWJ-67657, a p38 MAP-kinase inhibitor, on LPS-hyporesponsiveness. Faas MM; Moes H; Fijen JW; Muller Kobold AC; Tulleken JE; Zijlstra JG Clin Exp Immunol; 2002 Feb; 127(2):337-43. PubMed ID: 11876759 [TBL] [Abstract][Full Text] [Related]
8. p38 MAP kinase and MKK-1 co-operate in the generation of GM-CSF from LPS-stimulated human monocytes by an NF-kappa B-independent mechanism. Meja KK; Seldon PM; Nasuhara Y; Ito K; Barnes PJ; Lindsay MA; Giembycz MA Br J Pharmacol; 2000 Nov; 131(6):1143-53. PubMed ID: 11082122 [TBL] [Abstract][Full Text] [Related]
9. P38 MAPK mediates myocardial proinflammatory cytokine production and endotoxin-induced contractile suppression. Wang M; Sankula R; Tsai BM; Meldrum KK; Turrentine M; March KL; Brown JW; Dinarello CA; Meldrum DR Shock; 2004 Feb; 21(2):170-4. PubMed ID: 14752292 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological inhibition of Mannheimia haemolytica lipopolysaccharide and leukotoxin-induced cytokine expression in bovine alveolar macrophages. Malazdrewich C; Thumbikat P; Abrahamsen MS; Maheswaran SK Microb Pathog; 2004 Mar; 36(3):159-69. PubMed ID: 14726234 [TBL] [Abstract][Full Text] [Related]
11. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells. Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489 [TBL] [Abstract][Full Text] [Related]
12. Suppression of lipopolysaccharide-induced cytokine production of gingival fibroblasts by a soybean, Kunitz trypsin inhibitor. Kobayashi H; Yoshida R; Kanada Y; Fukuda Y; Yagyu T; Inagaki K; Kondo T; Kurita N; Suzuki M; Kanayama N; Terao T J Periodontal Res; 2005 Dec; 40(6):461-8. PubMed ID: 16302924 [TBL] [Abstract][Full Text] [Related]
13. IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase. Kumar S; Votta BJ; Rieman DJ; Badger AM; Gowen M; Lee JC J Cell Physiol; 2001 Jun; 187(3):294-303. PubMed ID: 11319753 [TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effect and selectivity profile of AS1940477, a novel and potent p38 mitogen-activated protein kinase inhibitor. Terajima M; Inoue T; Magari K; Yamazaki H; Higashi Y; Mizuhara H Eur J Pharmacol; 2013 Jan; 698(1-3):455-62. PubMed ID: 23183108 [TBL] [Abstract][Full Text] [Related]
15. Inhibitors of p38 suppress cytokine production in rheumatoid arthritis synovial membranes: does variable inhibition of interleukin-6 production limit effectiveness in vivo? Page TH; Brown A; Timms EM; Foxwell BM; Ray KP Arthritis Rheum; 2010 Nov; 62(11):3221-31. PubMed ID: 20589681 [TBL] [Abstract][Full Text] [Related]
16. Gram-positive and gram-negative bacteria do not trigger monocytic cytokine production through similar intracellular pathways. Rabehi L; Irinopoulou T; Cholley B; Haeffner-Cavaillon N; Carreno MP Infect Immun; 2001 Jul; 69(7):4590-9. PubMed ID: 11402003 [TBL] [Abstract][Full Text] [Related]
17. The identification of a small molecule inhibitor that specifically reduces T cell-mediated adaptive but not LPS-mediated innate immunity by T cell membrane-monocyte contact bioassay. Li YY; Bao M; Meurer J; Skuballa W; Bauman JG; Doecke WD; Zollner TM Immunol Lett; 2008 Apr; 117(1):114-8. PubMed ID: 18241931 [TBL] [Abstract][Full Text] [Related]
18. Defensin expression by the cornea: multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. McDermott AM; Redfern RL; Zhang B; Pei Y; Huang L; Proske RJ Invest Ophthalmol Vis Sci; 2003 May; 44(5):1859-65. PubMed ID: 12714616 [TBL] [Abstract][Full Text] [Related]
19. Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase. Wang SW; Pawlowski J; Wathen ST; Kinney SD; Lichenstein HS; Manthey CL Inflamm Res; 1999 Oct; 48(10):533-8. PubMed ID: 10563470 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. Scherle PA; Jones EA; Favata MF; Daulerio AJ; Covington MB; Nurnberg SA; Magolda RL; Trzaskos JM J Immunol; 1998 Nov; 161(10):5681-6. PubMed ID: 9820549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]